Search Result "Edoxaban (DU"

Update on Pharmacologic Approaches to Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer?

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 350-357
Author(s): Oliver Wolfram, Matthias Hammwoehner, Felix Gramley, Andreas Goette

Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales

Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 13 Year: 2016 Page: 1506-1529
Author(s): Guyan Liang,J. Phillip Bowen

New Thrombin and Factor Xa Inhibitors for Primary and Secondary Prevention of Ischaemic Stroke

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 2 Year: 2013 Page: 242-251
Author(s): Lisa Winstanley, Ruoling Chen

Atrial Fibrillation – New Frontiers in Anticoagulation

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14 Issue: 1 Year: 2014 Page: 45-49
Author(s): Ranji Thomas,Pierre Le Page,Andrew R.J. Mitchell

Review Article

Personalized Approaches to Cardiovascular Disease: Insights intoFDA-Approved Interventions and Clinical Pharmacogenetics

Journal: Current Pharmaceutical Design
Volume: 30 Issue: 21 Year: 2024 Page: 1667-1680
Author(s): Hamid Reza Rahimi,Hawraa Ibrahim Alshakarchi,Ibrahim Saeed Gataa,Seyed Mahdi Hassanian,Gordon A. Ferns

Novel Anticoagulants: New Evidence for Emerging Drugs and Their Potential Application in Major Lower Limb Surgery

Journal: Current Vascular Pharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 54-60
Author(s): Vassilios S. Nikolaou, Paul J. Harwood, Efthimios J. Karadimas, Hiang Boon Tan, Peter V. Giannoudis

Emerging Anticoagulant Therapies for Atrial Fibrillation: New Options, New Challenges

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 27 Year: 2012 Page: 4688-4698
Author(s): R. A. Mangiafico,M. Mangiafico

Review Article

Direct Oral Anticoagulants use in Patients with Stable Coronary ArteryDisease, Acute Coronary Syndrome or Undergoing Percutaneous CoronaryIntervention

Journal: Current Pharmaceutical Design
Volume: 29 Issue: 35 Year: 2023 Page: 2787-2794
Author(s):

Entering the Era of Non-Basic P1 Site Groups: Discovery of Xarelto™ (Rivaroxaban)

Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 257-269
Author(s): Alexander Straub, Susanne Roehrig, Alexander Hillisch

Systematic Review Article

Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis

Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 341-349
Author(s): Abdulla Shehab,Akshaya S. Bhagavathula,Tamrat B. Abebe,Tadesse M. Abegaz,Asim A. Elnour,Hani M. Sabbour,Masood Uzzafer,Ahmed Hersi,Adel K. Hamad

Previous   Next

Go To   Results 1 - 1 of 17

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy